2024
Maternal and Newborn Outcomes of SARS-CoV-2/COVID-19 and Pregnancy: Parallels and Contrasts with Human Immunodeficiency Virus/Acquired Immunodeficiency Syndrome
Li D, Zhang J, Zhang X, Chang Y, Vermund S. Maternal and Newborn Outcomes of SARS-CoV-2/COVID-19 and Pregnancy: Parallels and Contrasts with Human Immunodeficiency Virus/Acquired Immunodeficiency Syndrome. Medical Research Archives 2024, 12: 10.18103/mra.v12i4.5205. PMID: 39118854, PMCID: PMC11309002, DOI: 10.18103/mra.v12i4.5205.Peer-Reviewed Original ResearchHuman immunodeficiency virus/acquired immunodeficiency syndromeHuman immunodeficiency virusHuman immunodeficiency virus-infected womenAdherence to antiretroviral therapyNeonatal outcomesImmunodeficiency virusImmunodeficiency syndromeIntensive care unitAntiretroviral therapySARS-CoV-2Maternal mortalityRisk of mother-to-child transmissionVertical transmissionVertical transmission of human immunodeficiency virusClinical managementTransmission of human immunodeficiency virusImpact of human immunodeficiency virusIncreased risk of maternal mortalityHuman immunodeficiency virus controlPoor adherence to antiretroviral therapySARS-CoV-2 vertical transmissionVertical transmission of SARS-CoV-2Pregnant individualsMother-to-child transmissionNeonatal intensive care unit
2022
No evidence of fetal defects or anti-syncytin-1 antibody induction following COVID-19 mRNA vaccination
Lu-Culligan A, Tabachnikova A, Pérez-Then E, Tokuyama M, Lee HJ, Lucas C, Monteiro V, Miric M, Brache V, Cochon L, Muenker MC, Mohanty S, Huang J, Kang I, Dela Cruz C, Farhadian S, Campbell M, Yildirim I, Shaw AC, Ma S, Vermund SH, Ko AI, Omer SB, Iwasaki A. No evidence of fetal defects or anti-syncytin-1 antibody induction following COVID-19 mRNA vaccination. PLOS Biology 2022, 20: e3001506. PMID: 35609110, PMCID: PMC9129011, DOI: 10.1371/journal.pbio.3001506.Peer-Reviewed Original ResearchConceptsCOVID-19 mRNA vaccinationMRNA vaccinationEarly pregnancyFetal sizeCoronavirus disease 2019 (COVID-19) mRNA vaccinationSevere acute respiratory syndrome coronavirus 2Acute respiratory syndrome coronavirus 2Respiratory syndrome coronavirus 2Maternal antibody statusAdverse neonatal outcomesSyndrome coronavirus 2Birth defectsPolyinosinic-polycytidylic acidCrown-rump lengthGross birth defectsUnvaccinated adultsMaternal illnessNeonatal outcomesVaccinated adultsAntibody statusTLR3 agonistEarly immunizationMurine pregnancyAntibody inductionCoronavirus 2